发明名称 |
LYOPHILIZED VIRAL FORMULATIONS |
摘要 |
Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage. |
申请公布号 |
US2015224198(A1) |
申请公布日期 |
2015.08.13 |
申请号 |
US201514693100 |
申请日期 |
2015.04.22 |
申请人 |
Oncolytics Biotech Inc. |
发明人 |
Coffey Matthew C.;Serl Sarah;Pavliv Leo |
分类号 |
A61K47/26;C12N7/00;A61K47/02;A61K35/765 |
主分类号 |
A61K47/26 |
代理机构 |
|
代理人 |
|
主权项 |
1. A viral formulation, comprising:
(a) a purified virus; and (b) a non-viral composition comprising:
(i) sucrose;(ii) Mg2+; and(iii) a non-ionic surfactant, wherein the viral formulation is lyophilized; wherein the non-viral composition, prior to lyophilization, is a liquid non-viral composition further comprising a liquid carrier; wherein the concentration of sucrose in the liquid non-viral composition, prior to lyophilization, is less than 5% based on the weight of the liquid non-viral composition; wherein the liquid non-viral composition, excluding the liquid carrier, is substantially free of monovalent cationic salts, non-sucrose polyols, and carboxylates; and wherein the non-viral composition is provided in an amount effective to stabilize the purified virus. |
地址 |
Calgary CA |